Motivated by all these findings, we have designed and synthesised a series of pyrazolo[3,4-d]pyrimidines as novel small molecules targeting both EGFR and ErbB2 tyrosine kinases to be useful for treatment of cancer via inhibition of cell growth and induction of apoptosis. Here, EGFR is linked to cancer.